According to LeMaitre Vascular's latest financial reports the company has $90.17 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $82.69 M | 18.2% |
2021-12-31 | $69.95 M | 159.32% |
2020-12-31 | $26.97 M | -17.45% |
2019-12-31 | $32.68 M | -31.9% |
2018-12-31 | $47.98 M | 15.18% |
2017-12-31 | $41.66 M | 71.53% |
2016-12-31 | $24.28 M | -11.52% |
2015-12-31 | $27.45 M | 46.86% |
2014-12-31 | $18.69 M | 27.06% |
2013-12-31 | $14.71 M | -10.56% |
2012-12-31 | $16.44 M | -18.3% |
2011-12-31 | $20.13 M | -10.98% |
2010-12-31 | $22.61 M | -5.78% |
2009-12-31 | $24 M | 12.92% |
2008-12-31 | $21.25 M | -7.14% |
2007-12-31 | $22.88 M | -25.7% |
2006-12-31 | $30.8 M | 3670.87% |
2005-12-31 | $0.81 M | -20.21% |
2004-12-31 | $1.02 M | |
2002-12-31 | $0.33 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() Baxter BAX | $1.72 B | 1,809.58% | ๐บ๐ธ USA |
![]() Boston Scientific BSX | $0.57 B | 532.09% | ๐บ๐ธ USA |
![]() Edwards Lifesciences EW | $1.50 B | 1,573.71% | ๐บ๐ธ USA |
![]() Teleflex TFX | $0.25 B | 178.14% | ๐บ๐ธ USA |
![]() AngioDynamics ANGO | $44.62 M | -50.52% | ๐บ๐ธ USA |
![]() Cardiovascular Systems CSII | $0.13 B | 46.38% | ๐บ๐ธ USA |